Delivery Order SPE2DB22D3016-SPE2DB25FBGL3
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $29,737.84 and an ultimate completion date of September 10, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp has been awarded a $26,023.92 delivery order by the Defense Logistics Agency (DLA) for 30-count bottles of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV prevention and treatment. Issued on August 5, 2025, with a completion deadline of August 6, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is executed...
- The U.S. Department of Defense Medical Supply Chain awarded a $20,959.22 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity 30 units). This competitive, non-set-aside contract features firm fixed pricing and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 28, 2025, valued at $37,182.02. The contract calls for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for DESCOVY 200-25 mg tablets (30-count units) valued at $23,617.07. This firm fixed-price delivery order, which has a completion deadline of September 19, 2025, was awarded without a set-aside designation through competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of DESCOVY (200-25mg tablets, 30-count package) valued at $63,967.33. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a competitive award with no set-aside designation. The contract executes against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $9,639.01 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for $10,523.69 to supply Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $27,577.96 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30. This competitive award, which will be completed by August 12, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...